Filter
1697
Filtered Results: 1697
Text search:
diagnóstico
molecular
Featured
Recommendations
197
New Publications
287
Language
Document type
No document type
687
Guidelines
425
Studies & Reports
291
Manuals
118
Strategic & Response Plan
89
Fact sheets
45
Training Material
19
Situation Updates
11
Resource Platforms
6
Infographics
5
Brochures
1
Countries / Regions
India
80
Latin America and the Carribbean
71
Global
61
Western and Central Europe
54
Brazil
53
Africa
35
Eastern Europe
35
Colombia
33
Kenya
25
Argentina
24
Senegal
23
South Africa
22
Peru
21
Tanzania
21
Ethiopia
20
El Salvador
17
West and Central Africa
17
Venezuela
16
Russia
16
Mozambique
15
Germany
15
Congo, Democratic Republic of
15
East and Southern Africa
15
Paraguay
14
Rwanda
12
Chile
11
Malawi
11
Asia
11
South–East Asia Region
11
Zambia
11
Nigeria
10
Bolivia
10
Uganda
10
Sierra Leone
9
Cameroon
9
Philippines
9
Namibia
9
Angola
9
Ecuador
9
Ukraine
8
Ghana
8
Burkina Faso
8
Liberia
8
Bangladesh
7
Zimbabwe
6
Nepal
5
Benin
5
Guinea
5
Eastern Europe and Central Asia
5
France
5
Spain
5
Myanmar / Burma
5
USA
4
Haiti
4
Middle East and North Africa
4
Western Pacific Region
4
North America
4
Côte d’Ivoire / Ivory Coast
4
Indonesia
4
Madagascar
4
Pakistan
4
Cambodia
3
Uruguay
3
Mali
3
Eswatini/ Swaziland
3
Guatemala
3
Thailand
2
Mexico
2
China
2
Syria
2
Congo-Brazzaville
2
Niger
2
Burundi
2
Dominican Republic
2
Guinea-Bissau
2
Lebanon
2
Vietnam
2
Georgia
2
Honduras
2
Chad
2
Tajikistan
1
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Gambia
1
Togo
1
Canada
1
Laos
1
Estonia
1
Morocco
1
Mauritania
1
Italy
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Portugal
1
Nicaragua
1
Djibouti
1
Romania
1
Palestine
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
600
Clinical Guidelines
209
Pharmacy & Technologies
69
Public Health
53
Key Resources
23
Women & Child Health
19
Capacity Building
7
Toolboxes
TB
399
COVID-19
258
NTDs
146
AMR
98
HIV
80
Mental Health
66
Malaria
63
Rapid Response
46
Ebola & Marburg
44
Zika
30
Planetary Health
25
Pharmacy
25
2.0 Rapid Response
21
NCDs
17
Refugee
15
Polio
14
Caregiver
11
Cholera
8
Health Financing Toolbox
8
Specific Hazards
5
Global Health Education
5
Natural Hazards
4
Disability
4
Conflict
3
La publicación describe los procedimientos estandarizados para la atención integral de las personas diagnosticadas con tuberculosis y Virus de Inmunodeficiencia Humana en los servicios de salud a nivel nacional, así como los procesos de atención integral en las personas diagnosticadas con tuberc...
La guía se basa en las buenas prácticas existentes y se ha elaborado con la colaboración de enfermeras que trabajan en una amplia variedad de ámbitos, pero se enfoca principalmente en las áreas con recursos limitados. Representa el punto de vista del personal técnico ...
La Organización Panamericana de la Salud publica la tercera versión de la lista de dispositivos médicos prioritarios (LDMP) para el primer nivel de atención, elaborada de acuerdo con la realidad epidemiológica de los países de la Región de las Américas y adaptada al contexto de la pandemia d...
Objetivos.
Estimar la carga de tuberculosis (TB) en menores de 15 años y describir las características clínico, epidemiológicas y los resultados del tratamiento antituberculoso en Ecuador.
Métodos.
Se realizó un estudio retrospectivo utilizando los datos del programa nacional de TB de los...
La COVID-19 se ha propagado a los 54 países y territorios de las Américas. Para el 26 de mayo del 2020, los casos y las muertes en América Latina habían sobrepasado los de Europa y Estados Unidos en lo que se refiere al número diario de infecciones por coronavirus notificadas. Para junio, dos d...
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of...
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
WHO Recommended Surveillance Standards
recommended
Second editon. This document serves only as a guide to good practice and may help to harmonize surveillance activities. The purpose of this manual is to be a handy reference for key elements and contact information for all communicable diseases / syndromes associated with current WHO control program...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying markers and mortality risk factors in...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
